Robert C. Brunham | |
---|---|
Born | Creston, British Columbia, Canada |
Academic background | |
Education | BSc, MD, 1972, University of British Columbia |
Academic work | |
Institutions | University of British Columbia British Columbia Centre for Disease Control University of Manitoba |
Robert Conrad Brunham FRSC OBC is a Canadian infectious disease specialist. He is the former Director of the UBC Centre for Disease Control and executive director and Scientific Director of the British Columbia Centre for Disease Control.
Brunham was born and raised in Creston,British Columbia,Canada where he completed his undergraduate and medical degree at the University of British Columbia (UBC). [1] Following this,he trained under King Holmes at the University of Washington before becoming a physician scientist at the University of Manitoba. [2]
While working at the University of Manitoba,Brunham led their adult infectious disease program and became their Chair of Microbiology in 1987. In these roles,he focused his laboratory on addressing basic issues in chlamydial pathogenesis and host response. [1] During the HIV/AIDS pandemic in the 1980s,Brunham led efforts to treat Manitobans suffering from the disease. [3] He also was one of the first researchers to report on the sexually transmitted disease chlamydia. [4] As a result of this discovery,he established a chlamydia laboratory and focused on becoming an independent chlamydial biologist. [1] As a result of his research and academic success,Brunham was elected a Member of the American Society for Clinical Investigation in 1991. [5]
Brunham returned to his home province in 1999 to become the Academic Director of the British Columbia Centre for Disease Control (BCCDC). [1] At the BCCDC,he used the provincial databases to track the impact of Chlamydia control efforts on transmission dynamics and chronic infection sequelae,such as pelvic inflammatory disease,ectopic pregnancy,and infertility. [2] Brunham also led British Columbia's tactical and strategic response during the 2002–2004 SARS outbreak which included the testing and developing of a SARS vaccine. [6] [7] In recognition of his co-leadership in the SARS Accelerated Vaccine Initiative,Brunham was also the co-recipient of the 2005 Canadian Institutes of Health Research Partnership Award. [8]
Following the SARS outbreak,Brunham was amongst the first adopters of genomics technologies in public health which he demonstrated during a local tuberculosis outbreak. [9] [10] He also led an effort to sequence several hundred pandemic H1N1 genomes to explore viral evolutionary dynamics in the context of a pandemic at the 2010 Winter Olympics. [11] As a result of his efforts,Brunham was elected a Member of the Order of British Columbia. [10] Brunham stepped down from his role as Executive and Scientific Director of the BCCDC in 2014 to oversee the Vaccine Research Laboratory at the UBC Centre for Disease Control. Upon leaving his position,Brunham was awarded the Dr. Don Rix Award for Lifetime Achievement for his contributions during the HIV/AIDS and SARS pandemics. [12] The following year,he was also named a fellow of the Royal Society of Canada. [13]
During the COVID-19 pandemic,Brunham was appointed to sit on the Government of Canada's COVID-19 Vaccine Task Force to ensure the purchase,distribution and delivery of a safe and effective vaccine. [14] He also collaborated with Natalie Strynadka on a project aimed at predicting changes to SARS-CoV-2. [15]
A pandemic is an epidemic of an infectious disease that has spread across a large region,for instance multiple continents or worldwide,affecting a substantial number of individuals. Widespread endemic diseases with a stable number of infected individuals such as recurrences of seasonal influenza are generally excluded as they occur simultaneously in large regions of the globe rather than being spread worldwide.
The Public Health Agency of Canada is an agency of the Government of Canada that is responsible for public health,emergency preparedness and response,and infectious and chronic disease control and prevention.
Yuen Kwok-yung is a Hong Kong microbiologist,physician and surgeon. He is a prolific researcher,with most of his nearly 800 papers related to research on novel microbes or emerging infectious diseases. He led a team identifying the SARS coronavirus that caused the SARS pandemic of 2003–4,and traced its genetic origins to wild bats. During the ongoing COVID-19 pandemic,he has acted as expert adviser to the Hong Kong government.
Robert Ray Redfield Jr. is an American virologist who served as the Director of the U.S. Centers for Disease Control and Prevention and the Administrator of the Agency for Toxic Substances and Disease Registry from 2018 to 2021.
The 2009 swine flu pandemic in Canada was part of an epidemic in 2009 of a new strain of influenza A virus subtype H1N1 causing what has been commonly called swine flu. In Canada,roughly 10% of the populace has been infected with the virus,with 428 confirmed deaths;non-fatal individual cases are for the most part no longer being recorded. About 40% of Canadians have been immunized against H1N1 since a national vaccination campaign began in October 2009,with Canada among the countries in the world leading in the percentage of the population that has been vaccinated. The widespread effect of H1N1 in Canada raised concerns during the months leading to the XXI Olympic Winter Games,which took place in Vancouver in February 2010.
Mel Krajden is a physician and professor of Pathology and Laboratory Medicine at the University of British Columbia in Vancouver,British Columbia,Canada. He is the medical director of the BCCDC Public Health Laboratory. Dr. Krajden obtained his BSc,MD,and FRCPC at McGill University,followed by a fellowship in Infectious Diseases at Stanford University. He is also the medical director of the Public Health Laboratory at the British Columbia Centre for Disease Control. His research focuses on the prevention and care of hepatitis,human papillomavirus,and human immunodeficiency virus.
Francis Allan Plummer was a Canadian scientist,academic and HIV/AIDS researcher. He was "a recognized specialist in infectious diseases whose work influenced public health policy in Canada and abroad". He was Distinguished Professor Emeritus of Medicine and Medical Microbiology at the University of Manitoba and Scientific Director General,National Microbiology Laboratory.
John Brownstein is a Canadian epidemiologist and Professor of Medicine at the Harvard Medical School as well as the Chief Innovation Officer at Boston Children’s Hospital. His research focuses on development of computational methods in epidemiology for applications to public health also known as computational epidemiology or e-epidemiology He is also the founder of several global public health surveillance systems including HealthMap. He is most known for his work on global tracking of disease outbreaks.
Guan Yi is a Chinese virologist. In 2014,he was ranked as 11th in the world by Thomson Reuters among global researchers in the field of microbiology. He obtained his PhD in microbiology at the University of Hong Kong and is now a professor of microbiology at his alma mater. His research on the viral respiratory disease SARS helped the Chinese government avert the 2004 outbreak of this disease. He is the current director of the State Key Laboratory for Emerging Infectious Diseases University of Hong Kong. In early 2017,Guan warned that the H7N9 influenza virus "poses the greatest threat to humanity than any other in the past 100 years".
Theresa Tam is a Canadian physician and public servant who currently serves as the chief public health officer of Canada,who is the second-in-command of the Public Health Agency of Canada (PHAC). Tam initially took the role as acting CPHO following the retirement of her predecessor,Gregory Taylor,on 16 December 2016. She was formally appointed on 26 June 2017.
Daniel R. Lucey is an American physician,researcher,senior scholar and adjunct professor of infectious diseases at Georgetown University,and a research associate in anthropology at the Smithsonian National Museum of Natural History,where he has co-organised an exhibition on eight viral outbreaks.
The COVID-19 pandemic in British Columbia forms part of an ongoing worldwide pandemic of coronavirus disease 2019 (COVID-19),a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). On January 28,2020,British Columbia became the second province to confirm a case of COVID-19 in Canada. The first case of infection involved a patient who had recently returned from Wuhan,Hubei,China. The first case of community transmission in Canada was confirmed in British Columbia on March 5,2020.
Bonnie J. Fraser Henry is a Canadian physician and public servant who has been the provincial health officer at the British Columbia Ministry of Health since 2014. Henry is also a clinical associate professor at the University of British Columbia. She is a specialist in public health and preventive medicine,and is a family doctor. In her role as provincial health officer,Henry notably led the response to COVID-19 in British Columbia (BC).
Arnold Monto is an American physician and epidemiologist. At the University of Michigan School of Public Health,Monto is the Thomas Francis Jr. Collegiate Professor of Public Health,professor of epidemiology,and professor of global public health. His research focuses on the occurrence,prevention,and treatment of infectious diseases in industrialized and developing countries' populations.
Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System,and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute,and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic,McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.
Kelley Lee is a Tier 1 Canada Research Chair in Global Health Governance and Professor of Global Public Health in the Faculty of Health Sciences at Simon Fraser University. She has studied the impact of globalisation on public health,with a particular focus on the tobacco industry. During the COVID-19 pandemic Lee initiated and led the Pandemics and Borders Project to understand effective ways to mitigate the spread of SARS-CoV-2 through the effective use of travel measures.
Peter Daszak is a British zoologist,consultant and public expert on disease ecology,in particular on zoonosis. He is the president of EcoHealth Alliance,a nonprofit non-governmental organization that supports various programs on global health and pandemic prevention. He is also a member of the Center for Infection and Immunity at the Columbia University Mailman School of Public Health. He lives in Suffern,New York.
Science diplomacy is the collaborative efforts by local and global entities to solve global issues using science and technology as a base. In science diplomacy,collaboration takes place to advance science but science can also be used to facilitate diplomatic relations. This allows even conflicting nations to come together through science to find solutions to global issues. Global organizations,researchers,public health officials,countries,government officials,and clinicians have previously worked together to create effective measures of infection control and subsequent treatment. They continue to do so through sharing of resources,research data,ideas,and by putting into effect laws and regulations that can further advance scientific research. Without the collaborative efforts of such entities,the world would not have the vaccines and treatments we now possess for diseases that were once considered deadly such as tuberculosis,tetanus,polio,influenza,etc. Historically,science diplomacy has proved successful in diseases such as SARS,Ebola,Zika and continues to be relevant during the COVID-19 pandemic today.
Deborah M. Money is a Canadian obstetric and gynaecological infectious disease specialist. As a professor at the University of British Columbia,she was the first non-US President of the Infectious Diseases Society for Obstetrics and Gynecology from 2010 until 2012.
Agatha Jassem is a Canadian clinical microbiologist and the program head of the Virology Lab at the British Columbia Centre for Disease Control Public Health Laboratory,and a clinical assistant professor in the Department of Pathology &Laboratory Medicine at the University of British Columbia in Vancouver,British Columbia,Canada.